IN RARE FOR LIFE Trademark

Trademark Overview


On Tuesday, September 8, 2020, a trademark application was filed for IN RARE FOR LIFE with the United States Patent and Trademark Office. The USPTO has given the IN RARE FOR LIFE trademark a serial number of 90166041. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Thursday, August 10, 2023. This trademark is owned by Retrophin, Inc.. The IN RARE FOR LIFE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention of liver diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the prevention of kidney diseases and disorders; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the prevention of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the prevention of monogenic diseases and disorders; pharmaceutical preparations for the treatment of monogenic diseases and disorders; pharmaceutical preparations for the prevention of metabolic diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; therapeutic preparations for the prevention of liver diseases and disorders; therapeutic preparations for the treatment of liver diseases and disorders; ...
in rare for life

General Information


Serial Number90166041
Word MarkIN RARE FOR LIFE
Filing DateTuesday, September 8, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateThursday, August 10, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 15, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention of liver diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the prevention of kidney diseases and disorders; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the prevention of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the prevention of monogenic diseases and disorders; pharmaceutical preparations for the treatment of monogenic diseases and disorders; pharmaceutical preparations for the prevention of metabolic diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; therapeutic preparations for the prevention of liver diseases and disorders; therapeutic preparations for the treatment of liver diseases and disorders; therapeutic preparations for the prevention of kidney diseases and disorders; therapeutic preparations for the treatment of kidney diseases and disorders; therapeutic preparations for the prevention of central nervous system diseases and disorders; therapeutic preparations for the treatment of central nervous system diseases and disorders; therapeutic preparations for the prevention of monogenic diseases and disorders; therapeutic preparations for the treatment of monogenic diseases and disorders; therapeutic preparations for the prevention of metabolic diseases and disorders; therapeutic preparations for the treatment of metabolic diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 15, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTRAVERE THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NameRetrophin, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NameRetrophin, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Tuesday, February 13, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, February 13, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, January 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 12, 2023SOU EXTENSION 4 GRANTED
Thursday, January 5, 2023SOU EXTENSION 4 FILED
Thursday, January 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 15, 2022SOU EXTENSION 3 GRANTED
Thursday, August 4, 2022SOU EXTENSION 3 FILED
Thursday, August 4, 2022SOU TEAS EXTENSION RECEIVED
Thursday, January 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 5, 2022SOU EXTENSION 2 GRANTED
Wednesday, December 15, 2021SOU EXTENSION 2 FILED
Wednesday, January 5, 2022DIVISIONAL PROCESSING COMPLETE
Wednesday, December 15, 2021DIVISIONAL REQUEST RECEIVED
Monday, January 3, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 15, 2021TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, December 15, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, August 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 2, 2021SOU EXTENSION 1 GRANTED
Monday, August 2, 2021SOU EXTENSION 1 FILED
Monday, August 2, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 23, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, December 15, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 25, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 12, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 10, 2020ASSIGNED TO EXAMINER
Thursday, October 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 11, 2020NEW APPLICATION ENTERED